Levodopa is actually designed to *help* bradykinesia (slowness of movement), not worsen it. It works by boosting dopamine levels in the brain, which helps ease the classic Parkinson's symptoms like tremor, stiffness, and slowness.
Dyskinesia is not what levodopa targets — it's actually an unintended side effect that can Show Full Answer
Levodopa is actually designed to *help* bradykinesia (slowness of movement), not worsen it. It works by boosting dopamine levels in the brain, which helps ease the classic Parkinson's symptoms like tremor, stiffness, and slowness.
Dyskinesia is not what levodopa targets — it's actually an unintended side effect that can develop over time, typically after 4 to 10 years of use. Here's a simple breakdown of how levodopa relates to both:
- Bradykinesia (slowness): Levodopa helps *reduce* this symptom by replenishing dopamine
- Dyskinesia (involuntary movements): This can develop as a *side effect* of long-term levodopa use, due to fluctuating dopamine levels in the brain
Many people actually prefer being in the "on" state — when levodopa is working well — even if it means some dyskinesia, rather than dealing with severe stiffness and slowness.
It's always worth discussing any changes in symptoms with a neurologist, as dosage adjustments can make a big difference in managing both.
July 20
Join
Your Privacy Choices
